• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL organizes a free webinar on the European framework for orphan drugs

SFL will host a free webinar on ‘Regulatory considerations for orphan drugs’ on 24 February 2022, 4-5 pm CET.

SFL regulatory affairs experts will provide an introduction to the framework for orphan drugs in the European Union, the United Kingdom and Switzerland, and share their insights on opportunities and challenges for orphan drug designation and marketing authorization applications across these key regions. They will also provide insights into the revision of the EU orphan legislation.

The webinar will be presented by Anja Bührer>, Head Global Regulatory Affairs,Julien Gaudias>, Head EU Regulatory Affairs andBen Stockham>, Senior Consultant Global Regulatory Affairs at SFL.

You can register now via thislink>.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top